COMMUNIQUÉS West-GlobeNewswire
-
CARBIOS presents the results of its Annual General Meeting of June 18, 2026
22/06/2026 -
Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers
22/06/2026 -
Communiqué de presse : Sanofi nomme Paulo Fontoura à la tête de sa R&D
22/06/2026 -
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
22/06/2026 -
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
22/06/2026 -
Automatisation et interopérabilité de la pharmacie hospitalière : Deenova déploiera une plateforme intégrée de gestion du médicament au Policlinico di Milano
22/06/2026 -
Pharmacy automation interoperability: Deenova to deliver an integrated medication management platform at Policlinico di Milano
22/06/2026 -
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
21/06/2026 -
JellyFil Publishes Updated 2026 Product Information for Its Premium Gummy Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
20/06/2026 -
BreathEaseX Publishes Updated 2026 Product Information for Its Oral Spray Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
20/06/2026 -
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
19/06/2026 -
Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 9 juillet 2026
19/06/2026 -
Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026
19/06/2026 -
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19/06/2026 -
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
19/06/2026 -
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
19/06/2026 -
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/06/2026 -
Le professeur Mohamed Shamji prend la présidence de l’EAACI à l’issue du Congrès 2026 qui s’est tenu à Istanbul
19/06/2026 -
Boston Dental Named The Best Dentist in Boston
19/06/2026
Pages